Cromossomo launches US$2 billion DASA tender offer
Lefosse Advogados has advised Cromossomo, the investment vehicle of two controlling shareholders of Brazilian medical services company Diagnósticos da América (DASA), with a tender offer worth up to US$2 billion to acquire the diagnostics company’s outstanding shares.
To read more
Subscribe to Latin Lawyer
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Latin Lawyer experts.
Subscribe now